These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 9418320)

  • 21. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
    van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
    Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women.
    Noguchi S; Kasugai T; Miki Y; Fukutomi T; Emi M; Nomizu T
    Cancer; 1999 May; 85(10):2200-5. PubMed ID: 10326698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary breast cancer.
    Hicken GJ; Francis A; Harries SA
    Br J Surg; 1998 Apr; 85(4):570-1. PubMed ID: 9607548
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary breast cancer: a review.
    Arver B; Du Q; Chen J; Luo L; Lindblom A
    Semin Cancer Biol; 2000 Aug; 10(4):271-88. PubMed ID: 10966850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC).
    Shen D; Vadgama JV
    Oncol Res; 1999; 11(2):63-9. PubMed ID: 10489161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients.
    Díez O; Osorio A; Robledo M; Barroso A; Domènech M; Cortés J; Albertos J; Sanz J; Brunet J; SanRomán JM; Alonso MC; Baiget M; Benítez J
    Br J Cancer; 1999 Mar; 79(7-8):1302-3. PubMed ID: 10098775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRCA1 and BRCA2 mutation carriers as potential candidates for chemoprevention trials.
    Levy-Lahad E; Krieger M; Gottfeld O; Renbaum P; Klein G; Eisenberg S; Lahad A; Kaufman B; Catane R
    J Cell Biochem Suppl; 2000; 34():13-8. PubMed ID: 10762009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.
    Yazici H; Bitisik O; Akisik E; Cabioglu N; Saip P; Muslumanoglu M; Glendon G; Bengisu E; Ozbilen S; Dincer M; Turkmen S; Andrulis IL; Dalay N; Ozcelik H
    Br J Cancer; 2000 Sep; 83(6):737-42. PubMed ID: 10952777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.
    Pääkkönen K; Sauramo S; Sarantaus L; Vahteristo P; Hartikainen A; Vehmanen P; Ignatius J; Ollikainen V; Kääriäinen H; Vauramo E; Nevanlinna H; Krahe R; Holli K; Kere J
    Genet Epidemiol; 2001 Feb; 20(2):239-46. PubMed ID: 11180449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen.
    Spillman MA; Bowcock AM
    Oncogene; 1996 Oct; 13(8):1639-45. PubMed ID: 8895509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The glittering prize.
    Nat Genet; 1994 Oct; 8(2):105-6. PubMed ID: 7842002
    [No Abstract]   [Full Text] [Related]  

  • 34. [A genetic test for breast cancer: curse or blessing?].
    Sauer H
    Fortschr Med; 1995 Feb; 113(4):9-10. PubMed ID: 7713472
    [No Abstract]   [Full Text] [Related]  

  • 35. Sex steroid hormones and genetic susceptibility to breast and prostate cancer.
    Feigelson HS; Ross RK; Yu MC; Coetzee GA; Reichardt JK; Henderson BE
    Drug Metab Rev; 1998 May; 30(2):421-34. PubMed ID: 9606611
    [No Abstract]   [Full Text] [Related]  

  • 36. A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland.
    Arason A; Jonasdottir A; Barkardottir RB; Bergthorsson JT; Teare MD; Easton DF; Egilsson V
    J Med Genet; 1998 Jun; 35(6):446-9. PubMed ID: 9643283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BRCA1 is secreted and exhibits properties of a granin.
    Jensen RA; Thompson ME; Jetton TL; Szabo CI; van der Meer R; Helou B; Tronick SR; Page DL; King MC; Holt JT
    Nat Genet; 1996 Mar; 12(3):303-8. PubMed ID: 8589722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of breast cancer--an update.
    Lanier AP; Kaplan SD
    Alaska Med; 1995; 37(2):54-8. PubMed ID: 7661327
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetic predisposition testing for breast cancer.
    Audeh MW
    Cancer J Sci Am; 1997; 3(4):254-5. PubMed ID: 9263632
    [No Abstract]   [Full Text] [Related]  

  • 40. Acute care decisions--ethics in action.
    Haddad A
    RN; 1997 Jul; 60(7):17-20. PubMed ID: 9256796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.